BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 25925376)

  • 21. Inhibitory effects of antagonists of growth hormone releasing hormone on experimental prostate cancers are associated with upregulation of wild-type p53 and decrease in p21 and mutant p53 proteins.
    Stangelberger A; Schally AV; Rick FG; Varga JL; Baker B; Zarandi M; Halmos G
    Prostate; 2012 Apr; 72(5):555-65. PubMed ID: 21796649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TR4 nuclear receptor enhances prostate cancer initiation via altering the stem cell population and EMT signals in the PPARG-deleted prostate cells.
    Lin SJ; Yang DR; Wang N; Jiang M; Miyamoto H; Li G; Chang C
    Oncoscience; 2015; 2(2):142-50. PubMed ID: 25859557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TR4 nuclear receptor functions as a tumor suppressor for prostate tumorigenesis via modulation of DNA damage/repair system.
    Lin SJ; Lee SO; Lee YF; Miyamoto H; Yang DR; Li G; Chang C
    Carcinogenesis; 2014 Jun; 35(6):1399-406. PubMed ID: 24583925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Roles of testicular orphan nuclear receptors 2 and 4 in early embryonic development and embryonic stem cells.
    Shyr CR; Kang HY; Tsai MY; Liu NC; Ku PY; Huang KE; Chang C
    Endocrinology; 2009 May; 150(5):2454-62. PubMed ID: 19131575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subfertility with defective folliculogenesis in female mice lacking testicular orphan nuclear receptor 4.
    Chen LM; Wang RS; Lee YF; Liu NC; Chang YJ; Wu CC; Xie S; Hung YC; Chang C
    Mol Endocrinol; 2008 Apr; 22(4):858-67. PubMed ID: 18174360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The nuclear orphan receptor TR4 promotes proliferation of myeloid progenitor cells.
    Koritschoner NP; Madruga J; Knespel S; Blendinger G; Anzinger B; Otto A; Zenke M; Bartůnĕk P
    Cell Growth Differ; 2001 Nov; 12(11):563-72. PubMed ID: 11714637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of testicular orphan receptor 4 impairs normal myelination in mouse forebrain.
    Zhang Y; Chen YT; Xie S; Wang L; Lee YF; Chang SS; Chang C
    Mol Endocrinol; 2007 Apr; 21(4):908-20. PubMed ID: 17227886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth retardation and abnormal maternal behavior in mice lacking testicular orphan nuclear receptor 4.
    Collins LL; Lee YF; Heinlein CA; Liu NC; Chen YT; Shyr CR; Meshul CK; Uno H; Platt KA; Chang C
    Proc Natl Acad Sci U S A; 2004 Oct; 101(42):15058-63. PubMed ID: 15477591
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peroxisome proliferator-activated receptor gamma ligands induce cell cycle arrest and apoptosis in human renal carcinoma cell lines.
    Yang FG; Zhang ZW; Xin DQ; Shi CJ; Wu JP; Guo YL; Guan YF
    Acta Pharmacol Sin; 2005 Jun; 26(6):753-61. PubMed ID: 15916743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estrogen induces androgen-repressed SOX4 expression to promote progression of prostate cancer cells.
    Yang M; Wang J; Wang L; Shen C; Su B; Qi M; Hu J; Gao W; Tan W; Han B
    Prostate; 2015 Sep; 75(13):1363-75. PubMed ID: 26015225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeted inactivation of testicular nuclear orphan receptor 4 delays and disrupts late meiotic prophase and subsequent meiotic divisions of spermatogenesis.
    Mu X; Lee YF; Liu NC; Chen YT; Kim E; Shyr CR; Chang C
    Mol Cell Biol; 2004 Jul; 24(13):5887-99. PubMed ID: 15199144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peroxisome proliferator-activated receptor gamma regulates E-cadherin expression and inhibits growth and invasion of prostate cancer.
    Annicotte JS; Iankova I; Miard S; Fritz V; Sarruf D; Abella A; Berthe ML; Noël D; Pillon A; Iborra F; Dubus P; Maudelonde T; Culine S; Fajas L
    Mol Cell Biol; 2006 Oct; 26(20):7561-74. PubMed ID: 17015477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beyond peroxisome proliferator-activated receptor gamma signaling: the multi-facets of the antitumor effect of thiazolidinediones.
    Weng JR; Chen CY; Pinzone JJ; Ringel MD; Chen CS
    Endocr Relat Cancer; 2006 Jun; 13(2):401-13. PubMed ID: 16728570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The STAT3 Inhibitor Galiellalactone Effectively Reduces Tumor Growth and Metastatic Spread in an Orthotopic Xenograft Mouse Model of Prostate Cancer.
    Canesin G; Evans-Axelsson S; Hellsten R; Sterner O; Krzyzanowska A; Andersson T; Bjartell A
    Eur Urol; 2016 Mar; 69(3):400-4. PubMed ID: 26144873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of orphan receptors TR2, TR3, TR4, and p53 in heat-treated testis of cynomolgus monkeys (Macaca fascicularis).
    Zhang XS; Yuan JX; Liu T; Lue YH; Jin X; Tao SX; Hu ZY; Hikim AP; Swerdloff RS; Wang C; Liu YX
    J Androl; 2006; 27(3):405-13. PubMed ID: 16452526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thiazolidinediones inhibit hepatocarcinogenesis in hepatitis B virus-transgenic mice by peroxisome proliferator-activated receptor gamma-independent regulation of nucleophosmin.
    Galli A; Ceni E; Mello T; Polvani S; Tarocchi M; Buccoliero F; Lisi F; Cioni L; Ottanelli B; Foresta V; Mastrobuoni G; Moneti G; Pieraccini G; Surrenti C; Milani S
    Hepatology; 2010 Aug; 52(2):493-505. PubMed ID: 20683949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Premature aging with impaired oxidative stress defense in mice lacking TR4.
    Lee YF; Liu S; Liu NC; Wang RS; Chen LM; Lin WJ; Ting HJ; Ho HC; Li G; Puzas EJ; Wu Q; Chang C
    Am J Physiol Endocrinol Metab; 2011 Jul; 301(1):E91-8. PubMed ID: 21521714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lycorine is a novel inhibitor of the growth and metastasis of hormone-refractory prostate cancer.
    Hu M; Peng S; He Y; Qin M; Cong X; Xing Y; Liu M; Yi Z
    Oncotarget; 2015 Jun; 6(17):15348-61. PubMed ID: 25915156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-340 inhibits prostate cancer cell proliferation and metastasis by targeting the MDM2-p53 pathway.
    Huang K; Tang Y; He L; Dai Y
    Oncol Rep; 2016 Feb; 35(2):887-95. PubMed ID: 26718483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EphA3, induced by PC-1/PrLZ, contributes to the malignant progression of prostate cancer.
    Wu R; Wang H; Wang J; Wang P; Huang F; Xie B; Zhao Y; Li S; Zhou J
    Oncol Rep; 2014 Dec; 32(6):2657-65. PubMed ID: 25231727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.